Main Session
Sep
29
SS 27 - Advances in Multimodal Therapy for Glioblastoma: From Phase I to Phase III Trials
237 - Short-Course vs. Standard Radiotherapy with Concomitant and Maintenance Temozolomide in Patients Aged 18 to 70 years with Glioblastoma: An Open-Label, Randomized, Controlled, Phase 2, Non-Inferiority Trial
Presenter(s)
Samir Patel, MD - Associate Professor, University of Alberta, Edmonton, AB